Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 
Bank of Japan Eyes Further Rate Hikes Amid Middle East Tensions and Inflation Pressures 
What makes a good football coach? The reality behind the myths 
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines 
Oil Prices Slide as Iran Tensions Ease and U.S. Crude Stockpiles Swell 
U.S. Warplane Shot Down by Iran Amid Escalating Middle East Conflict 
March 2025 Jobs Report: Strong Headline Numbers Hide Deeper Economic Concerns 
Apple Turns 50: From Garage Startup to AI Crossroads 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
U.S. Dollar Climbs as Trump Escalates Rhetoric Against Iran 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
RBI Clamps Down on Rupee NDF Activity, Banks Face Steeper Losses 
U.S. Job Market Braces for Slow Recovery Amid Middle East Tensions and Economic Uncertainty 
Trump's Transgender Sports Ban Faces Enforcement Challenges 
How did sport become so popular? The ancient history of a modern obsession 
Coca-Cola Co. is buying 70 percent of BodyArmor for $5.6 billion in a deal that gives it full control of the company and values the sports drink brand at about $8 billion.
The shares that Coca-Cola would acquire are from BodyArmor's founders, major investors, and a group of professional athletes such as NBA’s James Harden and MLB’s Mike Trout who helped market the drink.
Coke already owns 30 percent of BodyArmor.
The deal amps up BodyArmor's rivalry with Gatorade.
BodyArmor is on track for $1.4 billion in retail sales this year.
